Euroapi S.A.
EAPIFOTCHealthcare● Active
$1.71
+$0.16(+10.32%)
Market Cap$163424880
P/E Ratio—
52W High$3.741
52W Low$1.27
Euroapi S.A. (EAPIF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EAPIF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 3, 2026EPS Actual
-$2.27
Revenue
$0.51B
Est. $0.54B · -5.0%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 3, 2026
After Market Close
▼ Miss Revenue
EAPIF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 28, 2026 | — | — | — | — | — | — |
| — Q1 FY2026 | Mar 3, 2026 | — | -$2.27 | — | $0.51B | $0.54B | -5.0% |
| ◌ Q3 FY2025 | Jul 29, 2025 | — | — | — | $0.49B | — | — |
| — Q1 FY2025 | Mar 3, 2025 | — | -$1.05 | — | $0.48B | — | — |
| — Q3 FY2024 | Jul 30, 2024 | — | -$0.39 | — | $0.48B | — | — |
| — Q2 FY2024 | Apr 5, 2024 | — | -$2.93 | — | $0.57B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.72 | — | $0.54B | $0.54B | +0.1% |
| ▼ Q1 FY2023 | Mar 8, 2023 | $0.17 | -$0.36 | -311.1% | $0.53B | $0.53B | +0.6% |
Q3 FY2026
Jul 28, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 3, 2026
EPS Actual
-$2.27
EPS Est.
—
EPS Surpr.
—
Revenue
$0.51B
Q3 FY2025
Jul 29, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
$0.49B
Q1 FY2025
Mar 3, 2025
EPS Actual
-$1.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.48B
Q3 FY2024
Jul 30, 2024
EPS Actual
-$0.39
EPS Est.
—
EPS Surpr.
—
Revenue
$0.48B
Q2 FY2024
Apr 5, 2024
EPS Actual
-$2.93
EPS Est.
—
EPS Surpr.
—
Revenue
$0.57B
Q2 FY2023
Jun 30, 2023
EPS Actual
$0.72
EPS Est.
—
EPS Surpr.
—
Revenue
$0.54B
Q1 FY2023
Mar 8, 2023Miss
EPS Actual
-$0.36
EPS Est.
$0.17
EPS Surpr.
-311.1%
Revenue
$0.53B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 3, 2026 | — | $2.54 | $2.37 | -6.69% |
| — Q1 FY2025 | Mar 3, 2025 | — | $3.02 | $3.15 | +4.30% |
| — Q3 FY2024 | Jul 30, 2024 | — | $2.83 | $2.83 | +0.00% |
| — Q2 FY2024 | Apr 5, 2024 | — | $2.75 | $2.99 | +8.73% |
| — Q2 FY2023 | Jun 30, 2023 | — | $11.39 | $11.39 | +0.00% |
| ▼ Q1 FY2023 | Mar 8, 2023 | -311.1% | $16.50 | $13.30 | -19.39% |
| — Q3 FY2022 | Sep 1, 2022 | — | $15.00 | $23.40 | +56.00% |
| — Q2 FY2022 | May 3, 2022 | — | No price data | $14.50 | — |
Q1 FY2026-6.69%
Report Date
Mar 3, 2026
EPS Beat/Miss
—
Price Before
$2.54
Price After
$2.37
Q1 FY2025+4.30%
Report Date
Mar 3, 2025
EPS Beat/Miss
—
Price Before
$3.02
Price After
$3.15
Q3 FY2024+0.00%
Report Date
Jul 30, 2024
EPS Beat/Miss
—
Price Before
$2.83
Price After
$2.83
Q2 FY2024+8.73%
Report Date
Apr 5, 2024
EPS Beat/Miss
—
Price Before
$2.75
Price After
$2.99
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$11.39
Price After
$11.39
Q1 FY2023-19.39%
Report Date
Mar 8, 2023
EPS Beat/Miss
-311.1%
Price Before
$16.50
Price After
$13.30
Q3 FY2022+56.00%
Report Date
Sep 1, 2022
EPS Beat/Miss
—
Price Before
$15.00
Price After
$23.40
Q2 FY2022—
Report Date
May 3, 2022
EPS Beat/Miss
—
Price Before
—
Price After
$14.50
Avg Miss Reaction-19.39%
Beat Rate0 / 8 quarters
Largest Move+56.00% (Q3 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EAPIF ends December
Euroapi S.A. (EAPIF) most recently reported earnings on March 3, 2026 for Q1 FY2026, posting EPS of $-2.27 (in line with the analyst consensus of —). The next EAPIF earnings date is expected around September 1, 2026.
Each quarter, investors track EAPIF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EAPIF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EAPIF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EAPIF earnings · 4 questionsEuroapi S.A.'s next earnings report is expected around September 1, 2026. EAPIF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EAPIF historically reports after market close (AMC).
EAPIF earnings datewhen is EAPIF earningsEAPIF next earnings datewhen does EAPIF report earningsEAPIF earnings calendar
▸ Source: FMP · Euroapi S.A. SEC filings · US GAAP · Euroapi S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026